Manhattan Therapeutic Research Foundation entered the industry of Commercial Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Jonathan Suarez by calling (718) 285-0588 during business hours. You can also write to the business’ Single Location at 37 West 26th St, New York City, New York NY 10010. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Manhattan Therapeutic Research Foundation |
Representative: | Jonathan Suarez |
Place of Business: | 37 West 26th St, New York City, NY 10010 |
Contact Number: | (718) 285-0588 |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2004 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Manhattan Therapeutic Research Foundation is a company operating from New York, New York providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Manhattan Therapeutic Research Foundation has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Jonathan Suarez at (718) 285-0588 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 37 West 26th St in New York City, New York 10010 and can be engaged online through the company website at , the company Twitter , and Facebook page .